[1]
Pavlovschi, E., Pantea, V., Borovic, D. and Tagadiuc, O. 2021. Study of ischemia modified albumin (IMA) as a biomarker in hypertensive retinopathy. Medicine and Pharmacy Reports. 94, 2 (Apr. 2021), 185-190. DOI:https://doi.org/10.15386/mpr-1815.